| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.0M | -7.7% |
| Cost of Revenue | $2.9M | -5.8% |
| Gross Profit | $5.1M | -8.9% |
| R&D Expense | $1.8M | -22.1% |
| SG&A Expense | $6.9M | -8.2% |
| Operating Income | -$7.7M | +49.8% |
| Pre-tax Income | -$7.1M | +37.4% |
| Income Tax | $39K | -25.0% |
| Net Income | -$7.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $693K | -84.5% |
| Accounts Receivable | $1.0M | -41.2% |
| Inventory | $2.5M | -34.2% |
| Current Assets | $4.6M | -55.4% |
| Total Assets | $4.8M | -55.1% |
| Current Liabilities | $5.0M | +32.0% |
| Total Liabilities | $5.0M | +26.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.4M | +73.9% |
| Investing Cash Flow | -$10K | +0.0% |
| Financing Cash Flow | $677K | -96.1% |
| +37.4% |
| EPS (Basic) | -$13.83 | -624.1% |
| EPS (Diluted) | -$13.83 | -624.1% |
| Stockholders' Equity |
| -$253K |
| -103.8% |